No takes yet. Share an insight, caveat, or question.
Methodological analysis demonstrates improved statistical power over standard regulatory guidelines for bioequivalence, indicating more accurate generic drug evaluation.
Berger et al. (1996) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: